Conversational agents (CAs) like Amazon’s Alexa and Apple’s Siri are designed to answer questions, offer suggestions, and even display empathy. However, new research indicates that they fall short compared to humans in interpreting and exploring a user’s experience.
CAs are powered by large language models (LLMs) that ingest massive amounts of human-produced data, and thus can be prone to the same biases as the humans from which the information comes.
Researchers from Cornell University, Olin College, and Stanford University tested this theory by prompting CAs to display empathy while conversing with or about 65 distinct human identities.
Value Judgments and Harmful Ideologies
The team found that CAs make value judgments about certain identities – such as gay and Muslim – and can be encouraging of identities related to harmful ideologies, including Nazism.
“I think automated empathy could have tremendous impact and huge potential for positive things – for example, in education or the health care sector,” said lead author Andrea Cuadra, now a postdoctoral researcher at Stanford.
“It’s extremely unlikely that it (automated empathy) won’t happen,” she said, “so it’s important that as it’s happening, we have critical perspectives so that we can be more intentional about mitigating the potential harms.”
Cuadra will present “The Illusion of Empathy? Notes on Displays of Emotion in Human-Computer Interaction” at CHI ’24, the Association of Computing Machinery conference on Human Factors in Computing Systems, May 11-18 in Honolulu. Research co-authors at Cornell University included Nicola Dell, associate professor, Deborah Estrin, professor of computer science, and Malte Jung, associate professor of information science.
Emotional Reactions vs. Interpretations
Researchers found that, in general, LLMs received high marks for emotional reactions, but scored low for interpretations and explorations. In other words, LLMs are able to respond to a query based on their training but are unable to dig deeper.
Dell, Estrin, and Jung said they were inspired to think about this work as Cuadra was studying the use of earlier-generation CAs by older adults.
“She witnessed intriguing uses of the technology for transactional purposes such as frailty health assessments, as well as for open-ended reminiscence experiences,” Estrin said. “Along the way, she observed clear instances of the tension between compelling and disturbing ‘empathy.’”
Reference: “The Illusion of Empathy? Notes on Displays of Emotion in Human-Computer Interaction” by Andrea Cuadra, Maria Wang, Lynn Andrea Stein, Malte F. Jung, Nicola Dell, Deborah Estrin and James A. Landay, 11 May 2024, CHI ’24.
DOI: 10.1145/3613904.3642336
News
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]















